IFNG and B-cell chronic lymphocytic leukemia: Interestingly, pre-treatment of NK cells with idelalisib inhibited their production of inflammatory cytokines, such as TNFα and IFNγ but did not alter their ADCC against CLL cells (38) (Figure 3).